Variant report
Variant | esv2754112 |
---|---|
Chromosome Location | chr20:40919680-40938007 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs34514663 | chr20:40919823-40919824 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574578406 | chr20:40919865-40919866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs188406936 | chr20:40919896-40919897 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75639506 | chr20:40919934-40919935 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs6124439 | chr20:40919935-40919936 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs575723284 | chr20:40920037-40920038 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs139739989 | chr20:40920086-40920087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs191648910 | chr20:40920141-40920142 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549705440 | chr20:40920144-40920145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569562361 | chr20:40920185-40920186 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs184518640 | chr20:40920188-40920189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs552325657 | chr20:40920198-40920199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs572359924 | chr20:40920237-40920238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs113602976 | chr20:40920243-40920244 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs189301036 | chr20:40920305-40920306 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs17316539 | chr20:40920313-40920314 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
17 | rs192651572 | chr20:40920318-40920319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs144436321 | chr20:40920327-40920328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs184389488 | chr20:40920354-40920355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs17225206 | chr20:40920359-40920360 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs556480282 | chr20:40920426-40920427 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs189269761 | chr20:40920427-40920428 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs73120061 | chr20:40920480-40920481 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs543617158 | chr20:40920516-40920517 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs181156011 | chr20:40920551-40920552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs376146579 | chr20:40920577-40920578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs561896234 | chr20:40920579-40920580 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567890020 | chr20:40920635-40920636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs146114832 | chr20:40920638-40920639 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs186387709 | chr20:40920639-40920640 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs563269041 | chr20:40920648-40920649 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs532126639 | chr20:40920662-40920663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs552233948 | chr20:40920671-40920672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs207477579 | chr20:40920714-40920715 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs140101404 | chr20:40920718-40920719 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528245006 | chr20:40920724-40920725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188891199 | chr20:40920727-40920728 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs578195140 | chr20:40920771-40920772 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs568172665 | chr20:40920807-40920808 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs537318075 | chr20:40920813-40920814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs181592624 | chr20:40920887-40920888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570751806 | chr20:40920908-40920909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs527629031 | chr20:40920945-40920946 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs538637945 | chr20:40920951-40920952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558574439 | chr20:40921003-40921004 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs371800746 | chr20:40921054-40921055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142332710 | chr20:40921060-40921061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs541134808 | chr20:40921106-40921107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs186253959 | chr20:40921127-40921128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs1573706 | chr20:40921149-40921150 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Autism | 22495311 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 21693616 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
colon cancer | 17210682 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 21264507 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Gastric cancer | 17167181 | CNVD |
Myeloproliferative neoplasm | 19047681 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Bladder cancer | 21909424 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 16608533 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Oral cancer | 21386901 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Prostate cancer | 18632612 | CNVD |
Gastric cancer | 22539939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cervical cancer | 16585170 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Infertility | 21528002 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Gastric cancer | 16891809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Schizophrenia | 23813976 | CNVD |
Colorectal cancer | 16774939 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:40919800-40922200 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
2 | chr20:40921200-40921800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
3 | chr20:40921400-40921800 | Enhancers | Pancreas | Pancrea |
4 | chr20:40922400-40922600 | Enhancers | Pancreatic Islets | Pancreatic Islet |
5 | chr20:40923000-40934200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
6 | chr20:40931400-40931800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
7 | chr20:40931600-40932800 | Enhancers | Fetal Brain Male | brain |
8 | chr20:40934200-40936000 | Strong transcription | Breast Myoepithelial Primary Cells | Breast |
9 | chr20:40936000-40942000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
10 | chr20:40936800-40939200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
11 | chr20:40937000-40938200 | Enhancers | HUES48 Cell Line | embryonic stem cell |
12 | chr20:40937200-40938000 | Enhancers | Fetal Brain Female | brain |
13 | chr20:40937200-40938400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
14 | chr20:40937200-40939200 | Enhancers | Brain Germinal Matrix | brain |
15 | chr20:40937400-40937800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
16 | chr20:40937400-40938000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
17 | chr20:40937400-40938200 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
18 | chr20:40937400-40938200 | Bivalent Enhancer | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
19 | chr20:40937400-40938600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
20 | chr20:40937600-40939200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
21 | chr20:40937800-40938200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
22 | chr20:40938000-40939400 | Weak transcription | Fetal Brain Female | brain |